How temporal patterns of medication adherence to antidepressants, bisphosphonates and statins are associated with healthcare cost

References

• 45 and Up Study Collaborators. 2008. “Cohort Profile: The 45 and Up Study.” International Journal of Epidemiology 37 (5): 941–947. 10.1093/ije/dym184.
   PubMed Web of Science ®Google Scholar
• Alhazami, M., V. M. Pontinha, J. A. Patterson, and D. A. Holdford. 2020. “Medication Adherence Trajectories: A Systematic Literature Review.” Journal of Managed Care & Specialty Pharmacy 26 (9): 1138–1152. doi:10.18553/jmcp.2020.26.9.1138.
   PubMed Web of Science ®Google Scholar
• Aubert, R. E., J. Yao, F. Xia, and S. B. Garavaglia. 2010. “Is There a Relationship Between Early Statin Compliance and a Reduction in Healthcare Utilization?” The American Journal of Managed Care 16 (6): 459–466.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. 2018. “Using PBS and MBS Data to Report on the Treatment and Management of Chronic Respiratory Conditions: 2016–17.” Canberra: AIHW.
   Google Scholar
• Australian Institute of Health and Welfare. 2021a. Medicare Benefits Schedule (MBS) Data Collection. https://www.aihw.gov.au/about-our-data/our-data-collections/medicare-benefits-schedule-mbs
   Google Scholar
• Australian Institute of Health and Welfare. 2021b. Pharmaceutical Benefits Scheme (PBS) Data Collection. https://www.aihw.gov.au/about-our-data/our-data-collections/pharmaceutical-benefits-scheme#:~:text=The%20Pharmaceutical%20Benefits%20Scheme%20_PBS,a%20claim%20has%20been%20processed
   Google Scholar
• Belotti, F., P. Deb, W. G. Manning, and E. T. Norton. 2015. “Two-Part Models.” The Stata Journal: Promoting Communications on Statistics and Stata 15 (1): 3–20. doi:10.1177/1536867X1501500102.
   Google Scholar
• Bl, J., and D. Nagin. 2012. “A Stata Plugin for Estimating Group-Based Trajectory Models.” Sociological Methods & Research 42 (4): 608–613. doi:10.1177/0049124113503141.
   Web of Science ®Google Scholar
• Briesacher, B. A., S. E. Andrade, R. A. Yood, and K. H. Kahler. 2007. “Consequences of Poor Compliance with Bisphosphonates.” Bone 41 (5): 882–887. doi:10.1016/j.bone.2007.07.009.
   PubMed Web of Science ®Google Scholar
• Centre for Health Record Linkage. n.d. How Record Linkage Works. https://www.cherel.org.au/how-record-linkage-works
   Google Scholar
• Chapman, R. H., A. A. Petrilla, J. S. Benner, J. S. Schwartz, and S. S. Tang. 2008. “Predictors of Adherence to Concomitant Antihypertensive and Lipid-Lowering Medications in Older Adults: A Retrospective, Cohort Study.” Drugs & Aging 25 (10): 885–892. doi:10.2165/00002512-200825100-00008.
   PubMed Web of Science ®Google Scholar
• Chien, T. Y., M. L. Lee, W. L. Wu, and H. W. Ting. 2019. “Exploration of Medical Trajectories of Stroke Patients Based on Group-Based Trajectory Modeling.” International Journal of Environmental Research and Public Health 16 (18): 3472. doi:10.3390/ijerph16183472.
   PubMed Web of Science ®Google Scholar
• Conn, V. S., and T. M. Ruppar. 2017. “Medication Adherence Outcomes of 771 Intervention Trials: Systematic Review and Meta-Analysis.” Preventive Medicine 99: 269–276. doi:10.1016/j.ypmed.2017.03.008.
   PubMed Web of Science ®Google Scholar
• Corrao, G., V. Conti, L. Merlino, A. L. Catapano, and G. Mancia. 2010. “Results of a Retrospective Database Analysis of Adherence to Statin Therapy and Risk of Nonfatal Ischemic Heart Disease in Daily Clinical Practice in Italy.” Clinical Therapeutics 32 (2): 300–310. doi:10.1016/j.clinthera.2010.02.004.
   PubMed Web of Science ®Google Scholar
• Cutler, R. L., A. Torres-Robles, E. Wiecek, B. Drake, N. Van der Linden, S. I. C. Benrimoj, and V. Garcia-Cardenas. 2019. “pharmacist-Led Medication Non-Adherence Intervention: Reducing the Economic Burden Placed on the Australian Health Care System.” Patient Preference and Adherence 13: 853–862. doi:10.2147/PPA.S191482.
   PubMed Web of Science ®Google Scholar
• Deb, P., E. C. Norton, and W. G. Manning. 2017. Health Econometrics Using Stata: Stata Press College Station. Texas, USA: TX.
   Google Scholar
• Deshpande, S., R. G. W. Quek, C. A. Forbes, S. de Kock, J. Kleijnen, S. R. Gandra, and R. J. Simpson. 2017. “A Systematic Review to Assess Adherence and Persistence with Statins.” Current Medical Research and Opinion 33 (4): 769–778. doi:10.1080/03007995.2017.1281109.
   PubMed Web of Science ®Google Scholar
• Dillon, P., S. M. Smith, P. Gallagher, and G. Cousins. 2019. “The Association Between Pharmacy Refill-Adherence Metrics and Healthcare Utilisation: A Prospective Cohort Study of Older Hypertensive Adults.” The International Journal of Pharmacy Practice 27 (5): 459–467. doi:10.1111/ijpp.12539.
   PubMed Web of Science ®Google Scholar
• Dillon, P., D. Stewart, S. M. Smith, P. Gallagher, and G. Cousins. 2018. “Group-Based Trajectory Models: Assessing Adherence to Antihypertensive Medication in Older Adults in a Community Pharmacy Setting.” Clinical Pharmacology & Therapeutics 103 (6): 1052–1060. doi:10.1002/cpt.865.
   PubMed Web of Science ®Google Scholar
• Eaddy, M. T., B. G. Druss, M. W. Sarnes, T. S. Regan, and L. E. Frankum. 2005. “Relationship of Total Health Care Charges to Selective Serotonin Reuptake Inhibitor Utilization Patterns Including the Length of Antidepressant Therapy–Results from a Managed Care Administrative Claims Database.” Journal of Managed Care Pharmacy 11 (2): 145–150. doi:10.18553/jmcp.2005.11.2.145.
   PubMedGoogle Scholar
• Eisenberg, T., T. Eisenberg, M. T. Wells, and M. Zhang. 2015. “Addressing the Zeros Problem: Regression Models for Outcomes with a Large Proportion of Zeros, with an Application to Trial Outcomes.” Journal of Empirical Legal Studies 12 (1): 161–186. doi:10.1111/jels.12068.
   Web of Science ®Google Scholar
• Eisenberg, D. F., H. Placzek, T. Gu, A. Krishna, and B. B. Tulsi. 2015. “Cost and Consequences of Noncompliance to Oral Bisphosphonate Treatment.” Journal of Managed Care & Specialty Pharmacy 21 (1): 56–65. doi:10.18553/jmcp.2015.21.1.56.
   PubMed Web of Science ®Google Scholar
• Falcaro, M., Y. Ben-Shlomo, M. King, N. Freemantle, and K. Walters. 2019. “Factors Associated with Discontinuation of Antidepressant Treatment After a Single Prescription Among Patients Aged 55 or Over: Evidence from English Primary Care.” Social Psychiatry and Psychiatric Epidemiology 54 (12): 1545–1553. doi:10.1007/s00127-019-01678-x.
   PubMed Web of Science ®Google Scholar
• Fatoye, F., P. Smith, T. Gebrye, and G. Yeowell. 2019. “Real-World Persistence and Adherence with Oral Bisphosphonates for Osteoporosis: A Systematic Review.” BMJ Open 9 (4): e027049. doi:10.1136/bmjopen-2018-027049.
   PubMed Web of Science ®Google Scholar
• Feldman, C. H., J. Collins, Z. Zhang, C. Xu, S. V. Subramanian, I. Kawachi, D. H. Solomon, and K. H. Costenbader. 2019. “Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors Among Medicaid Beneficiaries with Systemic Lupus Erythematosus.” Arthritis Care & Research 71 (11): 1419–1424. doi:10.1002/acr.23792.
   Web of Science ®Google Scholar
• Feldman, B., J. Shen, C. Chen, J. Shi, and H. Xiang. 2020. “Perceived Health After Adult Traumatic Brain Injury: A Group-Based Trajectory Modeling (GBTM) Analysis.” Brain Injury 34 (6): 741–750. doi:10.1080/02699052.2020.1753111.
   PubMed Web of Science ®Google Scholar
• Franklin, J. M., A. A. Krumme, A. Y. Tong, W. H. Shrank, O. S. Matlin, T. A. Brennan, and N. K. Choudhry. 2015. “Association Between Trajectories of Statin Adherence and Subsequent Cardiovascular Events.” Pharmacoepidemiology and Drug Safety 24 (10): 1105–1113. doi:10.1002/pds.3787.
   PubMed Web of Science ®Google Scholar
• Freedman, D. A. 2006. “On the So-Called “Huber Sandwich estimator” and “Robust Standard errors”.” The American Statistician 60 (4): 299–302. doi:10.1198/000313006X152207.
   Web of Science ®Google Scholar
• Gasparini, A. 2018. “Comorbidity: An R Package for Computing Comorbidity Scores.” Journal of Open Source Software 3 (23): 648. doi:10.21105/joss.00648.
   Google Scholar
• Gelenberg, A., M. Freeman, J. Markowitz, J. Rosenbaum, M. E. Thase, M. H. Trivedi and R. S. Van Rhoads. 2010. “American Psychiatric Association Practice Guideline for the Treatment of Patients with Major Depressive Disorder.” The American Journal of Psychiatry 167 (suppl 10): 9–118.
   Google Scholar
• Gellad, W. F., C. T. Thorpe, J. F. Steiner, and C. I. Voils. 2017. “The Myths of Medication Adherence.” Pharmacoepidemiology and Drug Safety 26 (12): 1437–1441. doi:10.1002/pds.4334.
   PubMed Web of Science ®Google Scholar
• Gentil, L., H. M. Vasiliadis, M. Préville, C. Bossé, and D. Berbiche. 2012. “Association Between Depressive and Anxiety Disorders and Adherence to Antihypertensive Medication in Community-Living Elderly Adults.” Journal of the American Geriatrics Society 60 (12): 2297–2301. doi:10.1111/j.1532-5415.2012.04239.x.
   PubMed Web of Science ®Google Scholar
• Giedrimiene, D., and R. King. 2017. “Abstract 207: Burden of Cardiovascular Disease (CVD) on Economic Cost. Comparison of Outcomes in US and Europe.” Circulation: Cardiovascular Quality and Outcomes 10 (suppl_3): A207-A. doi:10.1161/circoutcomes.10.suppl_3.207
   Google Scholar
• Greenberg, P. E., A.-A. Fournier, T. Sisitsky, C. T. Pike, and R. C. Kessler. 2015. “The Economic Burden of Adults with Major Depressive Disorder in the United States (2005 and 2010).” The Journal of Clinical Psychiatry 76 (2): 155–162. doi:10.4088/JCP.14m09298.
   PubMed Web of Science ®Google Scholar
• Guo, S., X. Li, X. Du, H. Liu, and G. Xie. 2017. “Group-Based Trajectory Analysis for Long-Term Use of Warfarin Therapy in Atrial Fibrillation Patients.” Studies in Health Technology and Informatics 245: 1024–1028.
   PubMedGoogle Scholar
• Hadji, P., N. Papaioannou, E. Gielen, M. F. Tepie, E. Zhang, I. Frieling, P. Geusens, et al. 2015. “Persistence, Adherence, and Medication-Taking Behavior in Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Practice in Germany, Austria, Greece, and Belgium: 12-Month Results from a European Non-Interventional Study.” Osteoporosis International 26 (10): 2479–2489. doi:10.1007/s00198-015-3164-4.
   PubMed Web of Science ®Google Scholar
• Hardin, J. W., J. W. Hardin, H. Jm, and J. Hilbe. 2007. Generalized Linear Models and Extensions. Texas, USA: Stata press.
   Google Scholar
• Harrison, T. N., S. F. Derose, T. C. Cheetham, V. Chiu, S. S. Vansomphone, K. Green, K. Tunceli, R. D. Scott, E. Marrett, and K. Reynolds. 2013. “Primary Nonadherence to Statin Therapy: Patients’ Perceptions.” The American Journal of Managed Care 19 (4): e133–9.
   PubMed Web of Science ®Google Scholar
• Heckman, J. J. 1976. “The Common Structure of Statistical Models of Truncation, Sample Selection and Limited Dependent Variables and a Simple Estimator for Such Models.” In Annals of Economic and Social Measurement, edited by Sanford V. Berg. Vol. 5, 475–492. Cambridge, MA: NBER.
   Google Scholar
• Ho, P. M., C. L. Bryson, and J. S. Rumsfeld. 2009. “Medication Adherence: Its Importance in Cardiovascular Outcomes.” Circulation 119 (23): 3028–3035. doi:10.1161/CIRCULATIONAHA.108.768986.
   PubMed Web of Science ®Google Scholar
• Ho, S. C., H. Y. Chong, N. Chaiyakunapruk, B. Tangiisuran, and S. A. Jacob. 2016. “Clinical and Economic Impact of Non-Adherence to Antidepressants in Major Depressive Disorder: A Systematic Review.” Journal of Affective Disorders 193: 1–10. doi:10.1016/j.jad.2015.12.029.
   PubMed Web of Science ®Google Scholar
• Holt, E. W., A. L. Rung, K. A. Leon, C. Firestein, and M. A. Krousel-Wood. 2014. “Medication Adherence in Older Adults: A Qualitative Study.” Educational Gerontology 40 (3): 198–211. doi:10.1080/03601277.2013.802186.
   PubMed Web of Science ®Google Scholar
• Hope, H. F., G. M. Binkley, S. Fenton, G. D. Kitas, S. M. M. Verstappen, and D. P. M. Symmons. 2019. “Systematic Review of the Predictors of Statin Adherence for the Primary Prevention of Cardiovascular Disease.” PLoS One 14 (1): e0201196. doi:10.1371/journal.pone.0201196.
   PubMed Web of Science ®Google Scholar
• Imaz, I., P. Zegarra, J. González-Enríquez, B. Rubio, R. Alcazar, and J. M. Amate. 2010. “Poor Bisphosphonate Adherence for Treatment of Osteoporosis Increases Fracture Risk: Systematic Review and Meta-Analysis.” Osteoporosis International 21 (11): 1943–1951. doi:10.1007/s00198-009-1134-4.
   PubMed Web of Science ®Google Scholar
• Independent Hospital Pricing Authority. 2012. National Hospital Cost Data Collection, AR-DRG Cost Weight Tables V6. 0x, Round 17 (Financial Year 2012–13). New South Wales, Australia: IHPA.
   Google Scholar
• Independent Hospitals Pricing Authority. 2013. National Efficient Price Determination 2013–2014. Sydney, Australia: Independent Hospitals Pricing Authority.
   Google Scholar
• Iuga, A. O., and M. J. McGuire. 2014. “Adherence and Health Care Costs.” Risk Management and Healthcare Policy 7: 35–44. doi:10.2147/RMHP.S19801.
   PubMedGoogle Scholar
• Janssen, D. G. A., E. Vermetten, T. C. G. Egberts, and E. R. Heerdink. 2019. “Discontinuation Rates of Antidepressant Use by Dutch Soldiers.” Military Medicine 184 (11–12): 868–874. doi:10.1093/milmed/usz060.
   PubMed Web of Science ®Google Scholar
• Jones, A. M., N. Rice, T. B. d’Uva, and S. Balia. 2013. Applied Health Economics. 2nd ed. London, UK: Routledge.
   Google Scholar
• Katon, W., C. R. Cantrell, M. C. Sokol, E. Chiao, and J. M. Gdovin. 2005. “Impact of Antidepressant Drug Adherence on Comorbid Medication Use and Resource Utilization.” Archives of Internal Medicine 165 (21): 2497–2503. doi:10.1001/archinte.165.21.2497.
   PubMedGoogle Scholar
• Kessler, D., A. Burns, D. Tallon, G. Lewis, S. MacNeill, J. Round, W. Hollingworth, et al. 2018. “Combining Mirtazapine with SSRIs or SNRIs for Treatment-Resistant Depression: The MIR RCT.” Health Technology Assessment (Winchester, England) 22 (63): 1‐136. doi:10.3310/hta22630.
   Web of Science ®Google Scholar
• Kirsch, F., C. Becker, C. Kurz, L. Schwettmann, and A. Schramm. 2020. “Effects of Adherence to Pharmacological Secondary Prevention After Acute Myocardial Infarction on Health Care Costs – an Analysis of Real-World Data.” BMC Health Services Research 20 (1): 1145. doi:10.1186/s12913-020-05946-4.
   PubMed Web of Science ®Google Scholar
• Kjellberg, J., A. D. Jorgensen, P. Vestergaard, R. Ibsen, F. Gerstoft, and A. Modi. 2016. “Cost and Health Care Resource Use Associated with Noncompliance with Oral Bisphosphonate Therapy: An Analysis Using Danish Health Registries.” Osteoporosis International 27 (12): 3535–3541. doi:10.1007/s00198-016-3683-7.
   PubMed Web of Science ®Google Scholar
• Krousel-Wood, M., T. Islam, P. Muntner, E. Holt, C. Joyce, D. E. Morisky, L. S. Webber, and E. D. Frohlich. 2010. “Association of Depression with Antihypertensive Medication Adherence in Older Adults: Cross-Sectional and Longitudinal Findings from CoSmo.” Annals of Behavioral Medicine 40 (3): 248–257. doi:10.1007/s12160-010-9217-1.
   PubMed Web of Science ®Google Scholar
• LaFleur, J., S. L. DuVall, T. Willson, T. Ginter, O. Patterson, Y. Cheng, K. Knippenberg, et al. 2015. “Analysis of Osteoporosis Treatment Patterns with Bisphosphonates and Outcomes Among Postmenopausal Veterans.” Bone 78: 174–185. doi:10.1016/j.bone.2015.04.022.
   PubMed Web of Science ®Google Scholar
• Lam, W. Y., and P. Fresco. 2015. “Medication Adherence Measures: An Overview.” BioMed Research International 2015: 217047. doi:10.1155/2015/217047.
   PubMed Web of Science ®Google Scholar
• Li, Y. C., and W. L. Huang. 2015. “Effects of Adherence to Statin Therapy on Health Care Outcomes and Utilizations in Taiwan: A Population-Based Study.” BioMed Research International 2015: 149573. doi:10.1155/2015/149573.
   PubMed Web of Science ®Google Scholar
• Lo-Ciganic, W. H., J. M. Donohue, B. L. Jones, S. Perera, J. M. Thorpe, C. T. Thorpe, Z. A. Marcum, and W. F. Gellad. 2016. “Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program.” Journal of General Internal Medicine 31 (9): 1052–1060. doi:10.1007/s11606-016-3747-6.
   PubMed Web of Science ®Google Scholar
• Long, J. S., and J. Freese. 2006. Regression Models for Categorical Dependent Variables Using. Stata: Stata press.
   Google Scholar
• MacEwan, J. P., F. M. Forma, J. Shafrin, A. Hatch, D. N. Lakdawalla, and J. P. Lindenmayer. 2016. “Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia.” Journal of Managed Care & Specialty Pharmacy 22 (11): 1349–1361. doi:10.18553/jmcp.2016.22.11.1349.
   PubMedGoogle Scholar
• MacEwan, J. P., A. R. Silverstein, J. Shafrin, D. N. Lakdawalla, A. Hatch, and F. M. Forma. 2018. “Medication Adherence Patterns Among Patients with Multiple Serious Mental and Physical Illnesses.” Advances in Therapy 35 (5): 671–685. doi:10.1007/s12325-018-0700-6.
   PubMed Web of Science ®Google Scholar
• Mealing, N. M., E. Banks, L. R. Jorm, D. G. Steel, M. S. Clements, and K. D. Rogers. 2010. “Investigation of Relative Risk Estimates from Studies of the Same Population with Contrasting Response Rates and Designs.” BMC Medical Research Methodology 10 (1): 26. doi:10.1186/1471-2288-10-26.
   PubMedGoogle Scholar
• Mehta, S. J., D. A. Asch, A. B. Troxel, R. Lim, J. Lewey, W. Wang, J. Zhu, L. Norton, N. Marcus, and K. G. Volpp. 2019. “Comparison of Pharmacy Claims and Electronic Pill Bottles for Measurement of Medication Adherence Among Myocardial Infarction Patients.” Medical Care 57 (2): e9–14. doi:10.1097/MLR.0000000000000950.
   PubMed Web of Science ®Google Scholar
• Modi, A. C., J. R. Rausch, and T. A. Glauser. 2011. “Patterns of Nonadherence to Antiepileptic Drug Therapy in Children with Newly Diagnosed Epilepsy.” Jama 305 (16): 1669–1676. doi:10.1001/jama.2011.506.
   PubMed Web of Science ®Google Scholar
• Nagin, D. S. 2014. “Group-Based Trajectory Modeling: An Overview.” Annals of Nutrition & Metabolism 65 (2–3): 205–210. doi:10.1159/000360229.
   PubMed Web of Science ®Google Scholar
• Nagin, D. S., and C. L. Odgers. 2010. “Group-Based Trajectory Modeling in Clinical Research.” Annual Review of Clinical Psychology 6 (1): 109–138. doi:10.1146/annurev.clinpsy.121208.131413.
   PubMed Web of Science ®Google Scholar
• Nelder, J. A., and R. W. Wedderburn. 1972. “Generalized Linear Models.” Journal of the Royal Statistical Society: Series A (General) 135 (3): 370–384. doi:10.2307/2344614.
   Web of Science ®Google Scholar
• NSW Ministry of Health. 2020a. NSW Admitted Patient Data Collection. https://www.cherel.org.au/media/38875/admitted-patient-data-collection_data-dictionary_march_2020_a.docx
   Google Scholar
• NSW Ministry of Health. 2020b. NSW Emergency Department Data Collection. https://www.cherel.org.au/media/60057/emergency-department-data-collection-data-dictionary_march_2020.docx
   Google Scholar
• NSW Ministry of Health. 2020c. Mortality Data, NSW Registry of Births, Deaths and Marriages Death Registrations, Australian Coordinating Registry Cause of Death Unit Record File. https://www.cherel.org.au/media/60080/nsw-mortality-data-dictionary_march_2020.docx
   Google Scholar
• O’Brien, J. 2021. Osteoporosis, Bone Fractures Cost Medicare $6.3B2019, August 29.
   Google Scholar
• Özdemir, T., İ. Şahin, İ. Avcı, B. Güngör, E. Durmaz, S. Tuğrul, M.I. Hayıroğlu, S. Kahyaoğlu, O. Karımov and E. Okuyan. 2017. “Assessment of Factors Related to Statin Non-Adherence in Patients with Established Coronary Artery Disease: A Single-Center Observational Study.” Turk Kardiyol Dern Ars 45 (8): 723–730. doi:10.5543/tkda.2017.89947.
   PubMedGoogle Scholar
• Park, R. E. 1966. “Estimation with Heteroscedastic Error Terms.” Econometrica (Pre-1986) 34 (4): 888. doi:10.2307/1910108.
   Web of Science ®Google Scholar
• Park, K. H., L. Tickle, and H. Cutler. 2022a. “Identifying Temporal Patterns of Adherence to Antidepressants, Bisphosphonates and Statins, and Associated Patient Factors.” SSM - Population Health 17: 100973. doi:10.1016/j.ssmph.2021.100973.
   PubMed Web of Science ®Google Scholar
• Park, K. H., L. Tickle, and H. Cutler. 2022b. “A Systematic Review and Meta-Analysis on Impact of Suboptimal Use of Antidepressants, Bisphosphonates, and Statins on Healthcare Resource Utilisation and Healthcare Cost.” PLoS One 17 (6): e0269836. doi:10.1371/journal.pone.0269836.
   PubMedGoogle Scholar
• Peterson, A. M., D. P. Nau, J. A. Cramer, J. Benner, F. Gwadry-Sridhar, and M. Nichol. 2007. “A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases.” Value in Health 10 (1): 3–12. doi:10.1111/j.1524-4733.2006.00139.x.
   PubMed Web of Science ®Google Scholar
• Proust-Lima, C., V. Philipps, and B. Liquet. 2015. “Estimation of Extended Mixed Models Using Latent Classes and Latent Processes: The R Package Lcmm.” Journal of Statistical Software 78 (2): 1–56. doi:10.18637/jss.v078.i02.
   Web of Science ®Google Scholar
• Rashki Kemmak, A., A. Rezapour, R. Jahangiri, S. Nikjoo, H. Farabi, and S. Soleimanpour. 2020. “Economic Burden of Osteoporosis in the World: A Systematic Review.” Medical Journal of the Islamic Republic of Iran 34: 154-. doi:10.47176/mjiri.34.154.
   PubMedGoogle Scholar
• Readdean, K. C., A. J. Heuer, and J. Scott Parrott. 2018. “Effect of Pharmacist Intervention on Improving Antidepressant Medication Adherence and Depression Symptomology: A Systematic Review and Meta-Analysis.” Research in Social and Administrative Pharmacy 14 (4): 321–331. doi:10.1016/j.sapharm.2017.05.008.
   PubMed Web of Science ®Google Scholar
• Robinson, R. L., S. R. Long, S. Chang, S. Able, O. Baser, R. L. Obenchain, and R. W. Swindle. 2006. “Higher Costs and Therapeutic Factors Associated with Adherence to NCQA HEDIS Antidepressant Medication Management Measures: Analysis of Administrative Claims.” Journal of Managed Care Pharmacy 12 (1): 43–54. doi:10.18553/jmcp.2006.12.1.43.
   PubMed Web of Science ®Google Scholar
• Rothman, K. J., J. E. Gallacher, and E. E. Hatch. 2013. “Why Representativeness Should Be Avoided.” International Journal of Epidemiology 42 (4): 1012–1014. doi:10.1093/ije/dys223.
   PubMed Web of Science ®Google Scholar
• Ruppar, T. M., P. S. Cooper, D. R. Mehr, J. M. Delgado, and J. M. Dunbar-Jacob. 2016. “Medication Adherence Interventions Improve Heart Failure Mortality and Readmission Rates: Systematic Review and Meta-Analysis of Controlled Trials.” Journal of the American Heart Association 5 (6). doi:10.1161/JAHA.115.002606.
   PubMed Web of Science ®Google Scholar
• Sansone, R. A., and L. A. Sansone. 2012. “Antidepressant Adherence: Are Patients Taking Their Medications?” Innovations in Clinical Neuroscience 9 (5–6): 41–46.
   PubMedGoogle Scholar
• Sax Institute. 2020. Technical Note: Linked MBS and PBS Data. Accessed 6 December 2021. https://www.saxinstitute.org.au/wp-content/uploads/Technical-Note-Linked-MBS-and-PBS-October-2020.pdf
   Google Scholar
• Schaffer, A. L., N. A. Buckley, T. A. Dobbins, E. Banks, and S. A. Pearson. 2015. “The Crux of the Matter: Did the Abc’s Catalyst Program Change Statin Use in Australia?” The Medical Journal of Australia 202 (11): 591–595. doi:10.5694/mja15.00103.
   PubMed Web of Science ®Google Scholar
• Schulberg, H. C., W. Katon, G. E. Simon, and A. J. Rush. 1998. “Treating Major Depression in Primary Care Practice: An Update of the Agency for Health Care Policy and Research Practice Guidelines.” Archives of General Psychiatry 55 (12): 1121–1127. doi:10.1001/archpsyc.55.12.1121.
   PubMed Web of Science ®Google Scholar
• Shafrin, J., F. Forma, E. Scherer, A. Hatch, E. Vytlacil, and D. Lakdawalla. 2017. “The Cost of Adherence Mismeasurement in Serious Mental Illness: A Claims-Based Analysis.” The American Journal of Managed Care 23 (5): e156–63.
   PubMed Web of Science ®Google Scholar
• Sigglekow, F., S. Horsburgh, and L. Parkin. 2020. “Statin Adherence is Lower in Primary Than Secondary Prevention: A National Follow-Up Study of New Users.” PLoS One 15 (11): e0242424. doi:10.1371/journal.pone.0242424.
   PubMed Web of Science ®Google Scholar
• Simpson, R. J., and P. Mendys. 2010. “The Effects of Adherence and Persistence on Clinical Outcomes in Patients Treated with Statins: A Systematic Review.” Journal of Clinical Lipidology 4 (6): 462–471. doi:10.1016/j.jacl.2010.08.026.
   PubMed Web of Science ®Google Scholar
• Thompson, W., D. E. Jarbøl, P. Haastrup, J. B. Nielsen, and A. Pottegård. 2019. “Statins in Older Danes: Factors Associated with Discontinuation Over the First 4 Years of Use.” Journal of the American Geriatrics Society 67 (10): 2050–2057. doi:10.1111/jgs.16073.
   PubMed Web of Science ®Google Scholar
• Tournier, M., Y. Moride, R. Crott, G. du Fort, and T. Ducruet. 2009. “Economic Impact of Non-Persistence to Antidepressant Therapy in the Quebec Community-Dwelling Elderly Population.” Journal of Affective Disorders 115 (1–2): 160–166. doi:10.1016/j.jad.2008.07.004.
   PubMed Web of Science ®Google Scholar
• Umeda, T., A. Hayashi, G. Fujimoto, Y. Piao, N. Matsui, and S. Tokita. 2019. “Medication Adherence/Persistence and Demographics of Japanese Dyslipidemia Patients on Statin-Ezetimibe as a Separate Pill Combination Lipid-Lowering Therapy ― An Observational Pharmacy Claims Database Study.” Circulation Journal 83 (8): 1689–1697. doi:10.1253/circj.CJ-18-1344.
   PubMed Web of Science ®Google Scholar
• Vega, C., R. V. Becker, L. Mucha, B. H. Lorenz, M. T. Eaddy, and A. O. Ogbonnaya. 2017. “Impact of Adherence to Antidepressants on Healthcare Outcomes and Costs Among Patients with Type 2 Diabetes and Comorbid Major Depressive Disorder.” Current Medical Research and Opinion 33 (10): 1879–1889. doi:10.1080/03007995.2017.1347092.
   PubMed Web of Science ®Google Scholar
• Verbosky, L. A., K. N. Franco, and J. P. Zrull. 1993. “The Relationship Between Depression and Length of Stay in the General Hospital Patient.” The Journal of Clinical Psychiatry 54 (5): 177–181.
   PubMed Web of Science ®Google Scholar
• Walsh, C. A., C. Cahir, and K. E. Bennett. 2021. “Longitudinal Medication Adherence in Older Adults with Multimorbidity and Association with Health Care Utilization: Results from the Irish Longitudinal Study on Ageing.” The Annals of Pharmacotherapy 55 (1): 5–14. doi:10.1177/1060028020937996.
   PubMed Web of Science ®Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. 2020. Guidelines for ATC Classification and DDD Assignment 2021. Oslo, Norway: Norwegian Institute of Public Health.
   Google Scholar
• Wooldridge, J. M. 2002. Econometric Analysis of Cross Section and Panel Data MIT Press. Vol. 108. Cambridge, MA: The MIT Press.
   Google Scholar
• World Health Organization. 2004. ICD-10 : International Statistical Classification of Diseases and Related Health Problems : Tenth Revision. 2nd ed. Geneva: World Health Organization.
   Google Scholar
• Wu, J., E. Seiber, V. A. Lacombe, M. C. Nahata, and R. Balkrishnan. 2011. “Medical Utilization and Costs Associated with Statin Adherence in Medicaid Enrollees with Type 2 Diabetes.” The Annals of Pharmacotherapy 45 (3): 342–349. doi:10.1345/aph.1P539.
   PubMed Web of Science ®Google Scholar
• Yap, A. F., T. Thirumoorthy, and Y. H. Kwan. 2016. “Systematic Review of the Barriers Affecting Medication Adherence in Older Adults.” Geriatrics & Gerontology International 16 (10): 1093–1101. doi:10.1111/ggi.12616.
   PubMed Web of Science ®Google Scholar
• Zhao, Y., S. Zabriski, and C. Bertram. 2014. “Associations Between Statin Adherence Level, Health Care Costs, and Utilization.” Journal of Managed Care & Specialty Pharmacy 20 (7): 703–713. doi:10.18553/jmcp.2014.20.7.703.
   PubMed Web of Science ®Google Scholar
• Zivin, K., S. Ratliff, M. M. Heisler, K. M. Langa, and J. D. Piette. 2010. “Factors Influencing Cost-Related Nonadherence to Medication in Older Adults: A Conceptually Based Approach.” Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research 13 (4): 338–345. doi:10.1111/j.1524-4733.2009.00679.x.
   PubMed Web of Science ®Google Scholar